AAA52397.1
[Other Products]
UniProt Secondary Accession #
UniProt Related Accession #
Molecular Weight
168,416 Da
NCBI Official Full Name
excision repair protein
NCBI Official Synonym Full Names
excision repair cross-complementation group 6
NCBI Official Synonym Symbols
CSB; CKN2; COFS; ARMD5; COFS1; RAD26; UVSS1 [Similar Products]
NCBI Protein Information
DNA excision repair protein ERCC-6; ATP-dependent helicase ERCC6; Cockayne syndrome group B protein; cockayne syndrome protein CSB; excision repair cross-complementing rodent repair deficiency, complementation group 6
UniProt Protein Name
DNA excision repair protein ERCC-6
UniProt Synonym Protein Names
ATP-dependent helicase ERCC6; Cockayne syndrome protein CSB
UniProt Synonym Gene Names
UniProt Entry Name
ERCC6_HUMAN
NCBI Summary for ERCC6
This gene encodes a DNA-binding protein that is important in transcription-coupled excision repair. The encoded protein has ATP-stimulated ATPase activity, interacts with several transcription and excision repair proteins, and may promote complex formation at DNA repair sites. Mutations in this gene are associated with Cockayne syndrome type B and cerebrooculofacioskeletal syndrome 1. Naturally-occurring readthrough transcription occurs between this gene and the adjacent PGBD3 gene (GeneID:267004), and results in a fusion protein that shares sequence with the product of each individual gene. The readthrough locus is represented by GeneID:101243544. [provided by RefSeq, Mar 2013]
UniProt Comments for ERCC6
ERCC6: Essential factor involved in transcription-coupled nucleotide excision repair which allows RNA polymerase II-blocking lesions to be rapidly removed from the transcribed strand of active genes. Upon DNA-binding, it locally modifies DNA conformation by wrapping the DNA around itself, thereby modifying the interface between stalled RNA polymerase II and DNA. It is required for transcription-coupled repair complex formation. It recruits the CSA complex (DCX(ERCC8) complex), nucleotide excision repair proteins and EP300 to the at sites of RNA polymerase II- blocking lesions. Defects in ERCC6 are the cause of Cockayne syndrome type B (CSB). Cockayne syndrome is a rare disorder characterized by cutaneous sensitivity to sunlight, abnormal and slow growth, cachectic dwarfism, progeroid appearance, progressive pigmentary retinopathy and sensorineural deafness. There is delayed neural development and severe progressive neurologic degeneration resulting in mental retardation. Two clinical forms are recognized: in the classical form or Cockayne syndrome type 1, the symptoms are progressive and typically become apparent within the first few years or life; the less common Cockayne syndrome type 2 is characterized by more severe symptoms that manifest prenatally. Cockayne syndrome shows some overlap with certain forms of xeroderma pigmentosum. Unlike xeroderma pigmentosum, patients with Cockayne syndrome do not manifest increased freckling and other pigmentation abnormalities in the skin and have no significant increase in skin cancer. Defects in ERCC6 are the cause of cerebro-oculo-facio- skeletal syndrome type 1 (COFS1); also known as COFS syndrome or Pena-Shokeir syndrome type 2. COFS is a degenerative autosomal recessive disorder of prenatal onset affecting the brain, eye and spinal cord. After birth, it leads to brain atrophy, hypoplasia of the corpus callosum, hypotonia, cataracts, microcornea, optic atrophy, progressive joint contractures and growth failure. Facial dysmorphism is a constant feature. Abnormalities of the skull, eyes, limbs, heart and kidney also occur. Defects in ERCC6 are a cause of De Sanctis-Cacchione syndrome (DSC); also known as xerodermic idiocy. DSC is an autosomal recessive syndrome consisting of xeroderma pigmentosum associated with mental retardation, retarded growth, gonadal hypoplasia and sometimes neurologic complications. Defects in ERCC6 are the cause of susceptibility to age- related macular degeneration type 5 (ARMD5). A form of age-related macular degeneration, a multifactorial eye disease and the most common cause of irreversible vision loss in the developed world. In most patients, the disease is manifest as ophthalmoscopically visible yellowish accumulations of protein and lipid that lie beneath the retinal pigment epithelium and within an elastin-containing structure known as Bruch membrane. Defects in ERCC6 are a cause of UV-sensitive syndrome type 1 (UVSS1). A rare autosomal recessive disorder characterized by photosensitivity and mild freckling but without neurological abnormalities or skin tumors. Patient exhibit a number of freckles, hypopigmented spots, telangiectases, and slightly dried skin in sun-exposed areas. Belongs to the SNF2/RAD54 helicase family.
Protein type: Helicase; DNA repair, damage; EC 3.6.1.-; Transcription regulation; EC 3.6.4.-
Chromosomal Location of Human Ortholog: 10q11.23
Cellular Component: nucleoplasm; transcription elongation factor complex; nucleolus; nucleus
Molecular Function: protein C-terminus binding; DNA-dependent ATPase activity; DNA helicase activity; protein binding; DNA binding; protein complex binding; protein N-terminus binding; protein tyrosine kinase activator activity; chromatin binding; ATP binding
Biological Process: transcription from RNA polymerase II promoter; response to superoxide; multicellular organism growth; positive regulation of RNA elongation; response to toxin; photoreceptor cell maintenance; RNA elongation from RNA polymerase I promoter; DNA repair; activation of JNK activity; response to UV-B; DNA damage response, signal transduction resulting in induction of apoptosis; base-excision repair; nucleotide-excision repair; transcription-coupled nucleotide-excision repair; response to gamma radiation; pyrimidine dimer repair; response to oxidative stress; regulation of RNA elongation; response to X-ray; activation of JNKK activity; response to UV
Disease: Lung Cancer; Cockayne Syndrome B; Macular Degeneration, Age-related, 5; De Sanctis-cacchione Syndrome; Uv-sensitive Syndrome 1; Cerebrooculofacioskeletal Syndrome 1
Research Articles on ERCC6
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice. It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Products associated with anti-ERCC6 antibody
Pathways associated with anti-ERCC6 antibody
Diseases associated with anti-ERCC6 antibody
Organs/Tissues associated with anti-ERCC6 antibody
|